First Personal Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

First Personal Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-245	Closed	-$21K	–	564
2019 Q2	$21K	Sell	245 -8	-3%	-$684	0.01%	394
2019 Q1	$22K	Buy	253 +20	+9%	+$1.85K	0.01%	385
2018 Q4	$20K	Buy	233 +18	+8%	+$1.71K	0.01%	372
2018 Q3	$21K	Buy	215 +47	+28%	+$4.69K	0.01%	401
2018 Q2	$16K	Sell	168 -360	-68%	-$31.5K	0.01%	425
2018 Q1	$43K	Sell	528 -141	-21%	-$12.1K	0.01%	465
2017 Q4	$60K	Buy	669 +155	+30%	+$13.5K	0.01%	433
2017 Q3	$48K	Hold	514	–	–	0.01%	431
2017 Q2	$47K	Buy	514 +13	+3%	+$1.18K	0.01%	433
2017 Q1	$44K	Hold	501	–	–	0.01%	420
2016 Q4	$42K	Buy	501 +20	+4%	+$1.72K	0.01%	407
2016 Q3	$45K	Buy	481 +20	+4%	+$1.88K	0.01%	296
2016 Q2	$36K	Buy	+461	New	+$39.2K	0.01%	324

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

First Personal Financial Services's BMRN Position: Q3 2019 in Review

First Personal Financial Services sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2019, closing a stake of 245 shares — an estimated $21K sold.

First Personal Financial Services first reported a position in BMRN in Q2 2016 and held it in 13 quarters. The position peaked at $60K in Q4 2017. 437 funds tracked by Wall St. Rank hold BMRN as of Q3 2019.

First Personal Financial Services reported no remaining BioMarin Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
First Personal Financial Services sold 245 BioMarin Pharmaceuticals shares in Q3 2019, an estimated $21K.
First Personal Financial Services first reported a position in BioMarin Pharmaceuticals in Q2 2016 and held it in 13 quarters.
First Personal Financial Services's BioMarin Pharmaceuticals position peaked at $60K in Q4 2017.
437 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2019.

Based on First Personal Financial Services's 13F filing for Q3 2019, filed 15 Oct 2019.